Lead sponsor
Beijing Suncadia Pharmaceuticals Co., Ltd
1 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of November 5, 2026.
1
Trials led
1
Ongoing
50
Total enrollment
1
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
1
Trials by status
Not yet recruiting
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SHR 3201 Injection in Healthy ParticipantsAge 18-60Ph 1Not yet recruiting50